Allogeneic Hematopoietic Stem Cell Transplantation Following the Use of Hypomethylating Agents among Patients with Relapsed or Refractory AML: Findings from an International Retrospective Study-Reference-Cited by-同舟云学术

Allogeneic Hematopoietic Stem Cell Transplantation Following the Use of Hypomethylating Agents among Patients with Relapsed or Refractory AML: Findings from an International Retrospective Study

Published:2018-08 Issue:8 Volume:24 Page:1754-1758
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Stahl Maximilian,DeVeaux Michelle,Montesinos Pau,Itzykson Raphaël,Ritchie Ellen K.,Sekeres Mikkael A.,Majhail Navneet,Barnard John,Podoltsev Nikolai A.,Brunner Andrew M.,Komrokji Rami S.,Bhatt Vijaya R.,Al-Kali Aref,Cluzeau Thomas,Santini Valeria,Roboz Gail J.,Fenaux Pierre,Litzow Mark^ORCID,Fathi Amir T.,Perreault Sarah,Kim Tae Kon,Prebet Thomas,Vey Norbert,Verma Vivek,Kobbe Guido,Bergua Juan,Serrano Josefina,Gore Steven D.,Zeidan Amer M.

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference5 articles.

1. How I treat refractory and early relapsed acute myeloid leukemia;Thol;Blood,2015

2. Allogeneic stem cell transplantation for refractory acute myeloid leukemia: a single center analysis of long-term outcome;Hemmati;Eur J Haematol,2015

3. Is it appropriate to offer allogeneic hematopoietic stem cell transplantation to patients with primary refractory acute myeloid leukemia?;Song;Bone Marrow Transplant,2005

4. Hypomethylating agents in relapsed and refractory AML: outcomes and their predictors in a large international patient cohort;Stahl;Blood Adv,2018

5. Salvage therapy for relapsed or refractory acute myeloid leukemia;Mangan;Ther Adv Hematol,2011

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hypomethylating agent-based therapies in older adults with acute myeloid leukemia – A joint review by the Young International Society of Geriatric Oncology and European Society for Blood and Marrow Transplantation Trainee Committee;Journal of Geriatric Oncology;2023-04

2. The mythological chimera and new era of relapse prediction post-transplant;Blood Reviews;2023-01

3. Decitabine treatment in 311 patients with acute myeloid leukemia: outcome and impact of TP53 mutations – a registry based analysis;Leukemia & Lymphoma;2021-01-05

4. Venetoclax plus hypomethylating agents or low-dose cytarabine in acute myeloid leukemia: all that glitters is gold?;Blood Cancer Journal;2020-01

5. Hypomethylating agents in the treatment of acute myeloid leukemia: A guide to optimal use;Critical Reviews in Oncology/Hematology;2019-08